What's new
Information from the previous month appears monthly in the newsletter “What'sNew” (link to registration page).
For the RSS feed with daily notifications of updates, use the link: RSS feed for “What'sNew”.
AGES eValidator New
19/02/2026
AGES eValidator Installation Instructions for installing the eValidator 24.2 The following basic requirements must be met: administrator privileges Microsoft Windows Installer 3.1 Microsoft .NET Frame
19/02/2026
Document Change Control EU Region eCTD Validation Criteria Version 8.2 June 2025 The order of changes appears reverse to the timely manner. The most recent change is listed on the top. Version Number
Referenced at:
Gabapentin New
PSUR-outcome
|
19/02/2026
Further information and amendments to the product information in all EU languages are available on the EMA website.
Safety warnings
|
Medical devices
|
18/02/2026
These tests for self-testing for the detection of sexually transmitted diseases (STDs) from the manufacturer Genesign Biotech (XIAMEN) Co, Ltd are also marketed under the brand name JAL Medical (Singapore) Pte. Ltd.
These products do not bear a CE mark, which means that they do not fulfil the requirements for in-vitro diagnostics. The BASG has information that the manufacturer has not carried out the required EU conformity assessment procedure. These products are therefore not marketable on the EU market.
Safety warnings
|
Blood & Tissue
|
17/02/2026
The donor/the donor gametes have been permanently blocked.
17/02/2026
Der Spender/die Spendergameten wurden gesperrt.
Referenced at:
Recall
|
Medicines
|
17/02/2026
Recall due to deactivated serial numbers
Dengue-France New
Safety warnings
|
Blood & Tissue
|
16/02/2026
The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Centre for Disease
Prevention and Control) that confirmed autochthonous dengue cases have been recorded in oversea departments of France.
16/02/2026
Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der ECDC (European Centre for Disease Prevention and Control) mitgeteilt, dass bestätigte autochthone Dengue-Fälle in Übersee-Départements Frankreichs verzeichnet wurden.
Referenced at:
Safety warnings
|
Blood & Tissue
|
16/02/2026
The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Centre for Disease
Prevention and Control) that confirmed autochthonous cases of chikungunya have been recorded in oversea departments of France.